ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Questionable 66 BCDDP Mastectomies Now Down To Three

February 17, 1978

Agencies Announce Plans To Monitor Gene Therapy Trials.

March 10, 2000

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995